Dr. Asad Javed, MD

Dr. Javed practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Dr. Javed's NPI, 1427339928, was assigned on August 29, 2011. Dr. Javed holds Iowa license MD-47327.

Dr. Javed's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Dr. Javed's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Dr. Javed is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Javed to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Javed practices, 4 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Javed's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Javed's licenses on file in 4 states: Iowa, Minnesota, Pennsylvania and Wisconsin.

CMS data shows 433 Medicare services from Dr. Javed across 5 procedure codes in 2024, for 136 Medicare patients. Medicare paid $28,475 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 136 Medicare patients who saw Dr. Javed in 2024. The largest group is 65 to 74, with 72 patients. 71% of them have high blood pressure, and 61% have high cholesterol. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Javed's median patient age at 71, with 57% women.

In 2024, Dr. Javed wrote 311 Medicare Part D claims for 51 patients. 66% of them were for generic drugs. CMS names the drug for 230 of them, across 10 drugs with 11 or more claims each, at $667,798 in total drug cost. In 2023, CMS named 96 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Javed for performance year 2024, reported as part of a group. Dr. Javed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Javed as offering telehealth.

Dmand AI links 6 papers to Dr. Javed, published from 2016 to 2023. The most frequent topics are Melanoma, Immunotherapy and Skin Neoplasms. Dr. Javed's most frequent co-authors are Asad Hassan Javed, MD, Mohammed Mahmoud Milhem, MBBS and Takami Sato, MD.

CMS Open Payments shows 12 general payments to Dr. Javed from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Immunocore Limited paid the most, $2,275.